Exploring anti-malarial potential of FDA approved drugs: an in silico approach.

Gayatri RamakrishnanNagasuma ChandraNarayanaswamy Srinivasan

Published in: Malaria journal (2017)

The drug-target associations predicted, primarily by taking advantage of evolutionary information, provide a valuable resource of attractive and feasible candidate drugs that can be readily taken through further stages of anti-malarial drug development pipeline.

Keyphrases

plasmodium falciparum
drug induced
molecular docking
healthcare
adverse drug
social media
climate change
data analysis